267 related articles for article (PubMed ID: 24523058)
21. Engineering an anti-granulocyte colony stimulating factor receptor nanobody for improved affinity.
Bakherad H; Farahmand M; Setayesh N; Ebrahim-Habibi A
Life Sci; 2020 Sep; 257():118052. PubMed ID: 32634431
[TBL] [Abstract][Full Text] [Related]
22. Identification of a CEACAM5 targeted nanobody for positron emission tomography imaging and near-infrared fluorescence imaging of colorectal cancer.
Xiao Y; Mei C; Xu D; Yang F; Yang M; Bi L; Mao J; Pang P; Li D
Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2305-2318. PubMed ID: 36914753
[TBL] [Abstract][Full Text] [Related]
23. Rapid tumor-labeling kinetics with a site-specific near-infrared anti-CEA nanobody in a patient-derived orthotopic xenograft mouse model of colon cancer.
Lwin TM; Turner MA; Amirfakhri S; Nishino H; Debie P; Cosman BC; Hoffman RM; Hernot S; Bouvet M
J Surg Oncol; 2021 Dec; 124(7):1121-1127. PubMed ID: 34309885
[TBL] [Abstract][Full Text] [Related]
24. Substrate specificity of soluble and membrane-associated ADP-ribosyltransferase ART2.1.
Zheng X; Morrison AR; Chung AS; Moss J; Bortell R
J Cell Biochem; 2006 Jul; 98(4):851-60. PubMed ID: 16453289
[TBL] [Abstract][Full Text] [Related]
25. Nanobody-based cancer therapy of solid tumors.
Kijanka M; Dorresteijn B; Oliveira S; van Bergen en Henegouwen PM
Nanomedicine (Lond); 2015 Jan; 10(1):161-74. PubMed ID: 25597775
[TBL] [Abstract][Full Text] [Related]
26. NIRF-Molecular Imaging with Synovial Macrophages-Targeting Vsig4 Nanobody for Disease Monitoring in a Mouse Model of Arthritis.
Zheng F; Luo S; Ouyang Z; Zhou J; Mo H; Schoonooghe S; Muyldermans S; De Baetselier P; Raes G; Wen Y
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31288389
[TBL] [Abstract][Full Text] [Related]
27. Theranostics in immuno-oncology using nanobody derivatives.
Lecocq Q; De Vlaeminck Y; Hanssens H; D'Huyvetter M; Raes G; Goyvaerts C; Keyaerts M; Devoogdt N; Breckpot K
Theranostics; 2019; 9(25):7772-7791. PubMed ID: 31695800
[TBL] [Abstract][Full Text] [Related]
28. (18)F-nanobody for PET imaging of HER2 overexpressing tumors.
Xavier C; Blykers A; Vaneycken I; D'Huyvetter M; Heemskerk J; Lahoutte T; Devoogdt N; Caveliers V
Nucl Med Biol; 2016 Apr; 43(4):247-52. PubMed ID: 27067045
[TBL] [Abstract][Full Text] [Related]
29. Improved Debulking of Peritoneal Tumor Implants by Near-Infrared Fluorescent Nanobody Image Guidance in an Experimental Mouse Model.
Debie P; Vanhoeij M; Poortmans N; Puttemans J; Gillis K; Devoogdt N; Lahoutte T; Hernot S
Mol Imaging Biol; 2018 Jun; 20(3):361-367. PubMed ID: 29090412
[TBL] [Abstract][Full Text] [Related]
30. CD8-β ADP-ribosylation affects CD8(+) T-cell function.
Lischke T; Schumacher V; Wesolowski J; Hurwitz R; Haag F; Koch-Nolte F; Mittrücker HW
Eur J Immunol; 2013 Jul; 43(7):1828-38. PubMed ID: 23575529
[TBL] [Abstract][Full Text] [Related]
31. Triggering of T-cell apoptosis by toxin-related ecto-ADP-ribosyltransferase ART2.
Scheuplein F; Adriouch S; Glowacki G; Haag F; Seman M; Koch-Nolte F
Ann N Y Acad Sci; 2003 Dec; 1010():296-9. PubMed ID: 15033737
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, preclinical validation, dosimetry, and toxicity of 68Ga-NOTA-anti-HER2 Nanobodies for iPET imaging of HER2 receptor expression in cancer.
Xavier C; Vaneycken I; D'huyvetter M; Heemskerk J; Keyaerts M; Vincke C; Devoogdt N; Muyldermans S; Lahoutte T; Caveliers V
J Nucl Med; 2013 May; 54(5):776-84. PubMed ID: 23487015
[TBL] [Abstract][Full Text] [Related]
33. Nanobody-based targeting of the macrophage mannose receptor for effective in vivo imaging of tumor-associated macrophages.
Movahedi K; Schoonooghe S; Laoui D; Houbracken I; Waelput W; Breckpot K; Bouwens L; Lahoutte T; De Baetselier P; Raes G; Devoogdt N; Van Ginderachter JA
Cancer Res; 2012 Aug; 72(16):4165-77. PubMed ID: 22719068
[TBL] [Abstract][Full Text] [Related]
34. Isolation and characterization of nanobodies against epithelial cell adhesion molecule as novel theranostic agents for cancer therapy.
Roshan R; Naderi S; Behdani M; Cohan RA; Ghaderi H; Shokrgozar MA; Golkar M; Kazemi-Lomedasht F
Mol Immunol; 2021 Jan; 129():70-77. PubMed ID: 33183767
[TBL] [Abstract][Full Text] [Related]
35. SPECT imaging of joint inflammation with Nanobodies targeting the macrophage mannose receptor in a mouse model for rheumatoid arthritis.
Put S; Schoonooghe S; Devoogdt N; Schurgers E; Avau A; Mitera T; D'Huyvetter M; De Baetselier P; Raes G; Lahoutte T; Matthys P
J Nucl Med; 2013 May; 54(5):807-14. PubMed ID: 23447654
[TBL] [Abstract][Full Text] [Related]
36. Multivalent nanobodies targeting death receptor 5 elicit superior tumor cell killing through efficient caspase induction.
Huet HA; Growney JD; Johnson JA; Li J; Bilic S; Ostrom L; Zafari M; Kowal C; Yang G; Royo A; Jensen M; Dombrecht B; Meerschaert KR; Kolkman JA; Cromie KD; Mosher R; Gao H; Schuller A; Isaacs R; Sellers WR; Ettenberg SA
MAbs; 2014; 6(6):1560-70. PubMed ID: 25484045
[TBL] [Abstract][Full Text] [Related]
37. Size and affinity kinetics of nanobodies influence targeting and penetration of solid tumours.
Debie P; Lafont C; Defrise M; Hansen I; van Willigen DM; van Leeuwen FWB; Gijsbers R; D'Huyvetter M; Devoogdt N; Lahoutte T; Mollard P; Hernot S
J Control Release; 2020 Jan; 317():34-42. PubMed ID: 31734445
[TBL] [Abstract][Full Text] [Related]
38. Near-infrared fluorescence imaging of gastrin releasing peptide receptor targeting in prostate cancer lymph node metastases.
Cai QY; Yu P; Besch-Williford C; Smith CJ; Sieckman GL; Hoffman TJ; Ma L
Prostate; 2013 Jun; 73(8):842-54. PubMed ID: 23280511
[TBL] [Abstract][Full Text] [Related]
39. Evaluation the potential of recombinant anti-CD3 nanobody on immunomodulatory function.
Moradi-Kalbolandi S; Sharifi-K A; Darvishi B; Majidzadeh-A K; Jalili N; Sadeghi S; Mosayebzadeh M; Sanati H; Salehi M; Farahmand L
Mol Immunol; 2020 Feb; 118():174-181. PubMed ID: 31884389
[TBL] [Abstract][Full Text] [Related]
40. Radiolabeled humanized anti-CD3 monoclonal antibody visilizumab for imaging human T-lymphocytes.
Malviya G; D'Alessandria C; Bonanno E; Vexler V; Massari R; Trotta C; Scopinaro F; Dierckx R; Signore A
J Nucl Med; 2009 Oct; 50(10):1683-91. PubMed ID: 19759100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]